Label: TING- tolnaftate aerosol, spray
- NDC Code(s): 63736-819-05
- Packager: Insight Pharmaceuticals LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated October 25, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient
- Purpose
- Uses
-
Warnings
For external use onlyFlammability Warning: Contents under pressure. Do not puncture or incinerate. Flammable mixture; do not use near fire or flame, or expose to heat or temperatures above 49°C (120°F). Use only as directed. Intentional misuse by deliberately concentrating and inhaling contents can be harmful or fatal.
-
Directions
▪ clean the affected area and dry thoroughly
▪ shake can well, hold 4" to 6" from skin. Spray a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor
▪ supervise children in the use of this product.
▪ pay special attention to the spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily.
▪ use daily for 4 weeks. If condition persists, consult a doctor.
- Other information
- Inactive ingredients
- Questions? 1-800-344-7239
- Principal Display Panel:
-
INGREDIENTS AND APPEARANCE
TING
tolnaftate aerosol, sprayProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:63736-819 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE 1.28 g in 128 g Inactive Ingredients Ingredient Name Strength BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ) ALCOHOL (UNII: 3K9958V90M) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63736-819-05 128 g in 1 CAN; Type 0: Not a Combination Product 07/27/2009 05/02/2025 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M005 07/27/2009 05/02/2025 Labeler - Insight Pharmaceuticals LLC (055665422)